What tests should I get after a Cholangiocarcinoma diagnosis

CholangiocarcinomaMay 22, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Tests After a Cholangiocarcinoma Diagnosis

After being diagnosed with cholangiocarcinoma (bile duct cancer), your oncology team will order several important tests to understand your cancer better and plan your treatment. Let me walk you through what to expect and why these tests matter.

Key Diagnostic and Staging Tests

Imaging Studies (if not already done):

  • CT or MRI scans of your abdomen and chest to see the size and location of the tumor and whether it has spread
  • PET scan (positron emission tomography) - shows areas of high metabolic activity that may indicate cancer
  • These help determine the stage of your cancer, which is critical for treatment planning

Blood Tests:

  • Liver function tests (bilirubin, alkaline phosphatase, ALT, AST) - measure how well your liver is working
  • CA 19-9 - a tumor marker (a protein produced by cancer cells) that can help track your cancer over time
  • Complete blood count (CBC) - checks your red blood cells, white blood cells, and platelets
  • Kidney function tests - important before starting chemotherapy

Tissue Analysis (if not already completed):

  • Pathology review of your biopsy or surgical specimen to confirm the diagnosis and identify important characteristics of your cancer cells
  • Molecular testing/biomarker analysis - tests that look for specific genetic mutations or protein markers in your cancer cells (like FGFR2 fusions, KRAS mutations, MSI/dMMR status, or PD-L1 expression). These findings can open up targeted therapy options.

Why These Tests Matter

These tests serve several purposes:

  1. Confirm the diagnosis and cancer type
  2. Determine how advanced the cancer is (staging)
  3. Identify treatment options - biomarker results often guide whether you're eligible for targeted therapies or immunotherapy
  4. Establish baseline measurements to track how well treatment is working
  5. Assess your overall health to ensure you can tolerate treatment

Questions to Ask Your Oncology Team

Since cholangiocarcinoma treatment depends heavily on these test results, here are specific questions to ask:

  1. "Which biomarker tests have been or will be performed on my tumor tissue, and what did they show?" (This is crucial - results like FGFR2 fusions or MSI-high status can determine if you're eligible for specific targeted drugs)

  2. "What is the stage of my cancer, and what does that mean for my treatment options?"

  3. "Based on my test results, what treatment approaches do you recommend, and why?"

  4. "How often will I need follow-up imaging and blood work, and what will we be looking for?"

  5. "Are there any clinical trials I might be eligible for based on my tumor characteristics?"

Important Next Steps

Request copies of all your test results and pathology reports. Understanding your specific tumor characteristics—especially biomarker status—is essential because it directly influences which treatments your doctor may recommend. Different cholangiocarcinoma subtypes (intrahepatic vs. extrahepatic) and different molecular profiles often have different treatment approaches.

Your healthcare team will use all this information together to create a personalized treatment plan. The combination of imaging, blood work, and tumor characteristics gives your oncologist the complete picture needed to make the best recommendations for your specific situation.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: